| 0.3334 -0.166 (-33.19%) | 05-20 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Aesthetic Medical International Holdings Group Limited operates as a specialist in diverse cosmetic medical services. The company's comprehensive portfolio features various surgical aesthetic procedures, such as ophthalmic surgery, rhinoplasty, breast enlargement, and liposuction. Additionally, it offers non-surgical aesthetic treatments, which encompass minimally invasive techniques and energy-based therapies like laser, ultrasound, and ultraviolet light applications. Beyond these, the group provides a broader range of general healthcare and other beauty-focused medical services, including internal medicine, urology, gynecology, obstetrics, dental care, dermatological treatments, and solutions for hair loss. With operations spanning 15 treatment centers, its facilities are located across China, Hong Kong, and Singapore. The enterprise was founded in 1997 and its main office is situated in Shenzhen, People's Republic of China.
Thu, 24 Apr 2025
AIH Stock Price, News & Analysis - Stock Titan
Mon, 20 May 2024
Aesthetic Medical receives delisting decision from Nasdaq hearings panel - TipRanks
Mon, 20 May 2024
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel - Yahoo Finance
Sun, 10 Mar 2024
Alternatives to Silicone Breast Implants and 10 Cheap Countries for Augmentation - Yahoo Finance
Sun, 27 Aug 2023
10 Best Cosmetic Surgery and Aesthetics Stocks to Buy - Yahoo Finance
Sat, 15 Aug 2020
Aesthetic Medical Internati... (AIH) Stock News - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|